FDA inspection

Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.: FDA inspection ending Jun 12, 2014

FDA inspection 886759 · No Action Indicated (NAI) · Changzhou

Key facts

Inspection ID 886759
Firm Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.
FEI number 3001599766
Address No. 302 Huzhuangtou, Sanhuangmiao, Zhenglu, Tianning
City Changzhou
Country China
Fiscal year 2014
Inspection end date Jun 12, 2014
Classification No Action Indicated (NAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • No Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections